SUBSCRIBE
Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (4): 465-469.doi: 10.3736/jcim20070422

• Literature Review • Previous Articles     Next Articles

Research on the chemical constituents and pharmacological activities of Liriope Lour.

Tao Jiang1,2, Lu-ping Qin1   

  1. 1. Department of Pharmacogonosy, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
    2. Shanghai Nabio Biotechnology Co., Ltd, Shanghai 201203, China Abstract
  • Online:2007-07-31 Published:2007-05-15

RichHTML

0

PDF (PC)

60

Like

Key words: plants, chemical principle, pharmacology

CLC Number: 

  • R931.71

"

编号 名称 来源 参考文献
1 ruscogenin3-O-α-L-rhamnopyranoside a 2
2* 25(S)-ruscogenin1-O-β-D-fucopyranoside-3-O-α-L-rhamnopyranoside(Ls-2) a, b 2, 3, 4
3 25(S)-ruscogenin1-O-α-L-rhamnopyranosyl(1→2)-β-D-fucopyranoside a, b 2, 3
4 ruscogenin3-O-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranoside a2
5 3-O-[α-L-rhamnopyranoside(1→2)][β-D-xylopyranosyl(1→3)]-β-D-glucopyranosides of diosgenin and yamogenin a 2
6 3-O-β-chacotriosides of diosgenin and yamogenin a 2
7 ruscogenin1-sulfate 3-O-α-L-rhamnopyranoside a 2
8 26-O-β-D-glucopyranosyl-22-O-methylfurost-5-ene-3β, 26-diol 3-O-β-chacotrioside a 2
9 25(S)-鲁斯可皂苷元-1-O-[α-L-吡喃鼠李糖基(1→2)][β-D-吡喃木糖基(1→3)]-β-D-吡喃夫糖苷 b, c 3, 5
10 β-sitosterolβ-D-glucopyranoside (Ls-1, Lm-1) b, c 4
11* 25(S)-ruscogenin1-O-β-D-xylopyranosido-3-O-α-L-rhamnopyranoside (Ls-3) b 4
12* 25(S)-ruscogenin1-O-α-L-rhamnopyranosyl(1→2)-β-D-xylopyranoside (Ls-4) b 4
13* 25(S)-ruscogenin1-O-[(2-O-acetyl)-α-L-rhamnopyranosyl(1→2)][β-D-xylopyranosyl(1→3)]-β-D-fucopyranoside (Ls-5 ) b 4
14* 25(S)-ruscogenin1-O-[(3-O-acetyl)-α-L-rhamnopyranosyl(1→2)][β-D-xylopyranosyl(1→3)]-β-D-fucopyranoside (Ls-6) b 4
15* yamogenin3-O-[α-L-rhamnopyranosyl(1→2)][β-D-xylopyranosyl(1→3)]-β-D-glucopyranoside (Ls-7) b 4
16* ruscogenin1-O-β-D-glucopyranosyl(1→2)]-β-D-fucopyranoside (Lm-2) c 4
17* ruscogenin1-O-[β-D-glucopyranoside(1→2)][β-D-xylopyranosyl(1→3)]-β-D-fucopyranoside (Lm-3) c 4
18* 25(S)-ruscogenin-1-O-[α-L-rhamnopyranosyl(1→2)][β-D-xylopyranosyl(1→3)]-β-D-fucopyranoside-3-O-α-L-rhamnopyranoside (Lirioproliosode A) b 5
19* 25(S)-ruscogenin-1-O-[3-O-acetyl-α-L-rhamnopyranosyl(1→2)]-β-D-fucopyranoside (Lirioproliosode B) b 5
20* 25(S)-ruscogenin(1-O-[2-O-acetyl-α-L-rhamnopyranosyl(1→2)]-β-D-fucopyranoside (Lirioproliosode C) b 5
21* ruscogenin(1-O-[2-O-acetyl-α-L-rhamnopyranosyl(1→2)]-β-D-fucopyranoside (Lirioproliosode D) b 5
22* 25(S)-ruscogenin1-O-β-D-fucopyranoside (Lm-4) c 6
23* pennogenin3-O-[4’-O-acetyl-α-L-rhamnopyranosyl(1→3)]-β-D-xylopyranosyl(1→4)]-β-D-glucopyranoside (Lm-5) c 6
24 25(R)鲁斯可皂苷元-1-O-β-D-吡喃葡萄糖-(1→2)-β-D-吡喃岩藻糖苷 c 7
25 25(R)鲁斯可皂苷元-1-O-β-D-吡喃木糖-(1→3)-β-D-吡喃岩藻糖苷 c 7
26 香草酸 c 7
27 对羟基桂皮酰酪胺 c 7
28 谷氨酸酐 c 7
29 熊果酸 c 7
30 齐墩果酸 c 7
31 正二十五烷酸 c 7
32 正三十一烷酸 c 7
33 门冬氨酸 d 8
34 苏氨酸 d 8
35 丝氨酸 d 8
36 丙氨酸 d 8

Figure 1

Structure of new saponin compounds"

[1] 余伯阳, 徐国钧 . 中药麦冬的资源利用研究[J]. 中草药, 1995,26(4):205-210
Yu BY, Xu GJ . Studies on resource utilization of Chinese drug dwarf lilyturf(Ophiopogon japonicus)[J]. Zhong Cao Yao, 1995,26(4):205-210
[2] 刘伟, 王著禄, 梁华清 . 湖北山麦冬化学成分的研究[J]. 药学学报, 1989,24(10):749-754
Liu W, Wang ZL, Liang HQ . Studies on the chemical constituents of Liriope spicata(Thunb.) Lour. var. proliferae Y. T. Ma[J]. Yao Xue Xue Bao, 1989,24(10):749-754
[3] Yoshiaki W, Shuichi S, Yoshitera I , et al. Comparative studies on the constituents of ophiopogonis tuber and its congeners. I: Studies of the constituents of the subterranean part of Liriope platyphylla Wang and Tang[J]. Chem Pharm Bull, 1983,31(6):1980-1990
[4] Yu BY, Hirai Y, Shoji J , et al. Comparative studies on the constituents of ophiopogonis tuber and its congeners. VI. Studies on the constituents of the subterranean part of Liriope spicata var. prolifera and L. muscari.(1)[J]. Chem Pharm Bull, 1990,38(7):1931-1935
[5] Yu BY, Qiu SX, Zaw K , et al. Steroidal glycosides from the subterranean parts of Liriope spicata var. prolifera[J]. Phytochemistry, 1996,43(1):201-206
doi: 10.1016/0031-9422(96)00228-2 pmid: 8987515
[6] Chen ZH, Wu T, Guo YL , et al. Two new steroidal glycosides from Liriopes muscari.(Decne.) Beilg[J]. Chin Chem Lett, 2006,17(1):31-34
[7] 程志红, 吴韬, 余伯阳 , 等. 短葶山麦冬化学成分的研究[J]. 中草药, 2005,36(6):823-826
Cheng ZH, Wu T, Yu BY , et al. Studies on the chemical constituents of Liriopes muscari.(Decne.) Beilg[J]. Zhong Cao Yao, 2005,36(6):823-826
[8] 吴秀英, 谢继红, 王唯玮 , 等. 山麦冬水溶性成分的研究[J]. 大连医学院学报, 1989,11(1):43-46
Wu XY, Xie JH, Wang WW , et al. Studies on the water-soluble active constituents of Liriope spicata(Thunb.) Lour. var. proliferae Y.T. Ma[J]. Dalian Yi Xue Yuan Xue Bao, 1989,11(1):43-46
[9] 高广猷, 李云勋, 段鹏 , 等. 山麦冬的水溶性提取物对麻醉猫血流动力学的影响[J]. 中国中药杂志, 1989,9(40):552-554
Gao GY, Li YX, Duan P , et al. Haemodynamic effects of water-soluble extract of Liriope spicata(Thunb.) Lour. var. proliferae Y.T. Ma on anaesthetized cat[J]. Zhongguo Zhong Yao Za Zhi, 1989,9(40):552-554
[10] 桂苡, 高广猷, 韩国柱 , 等. 山麦冬对心血管系统药理作用的研究[J]. 中草药, 1984,15(3):21-23
Gui Y, Gao GY, Han GZ , et al. Experimental observation on the effects of cardiovascular of Liriope spicata(Thunb.) Lour. var. proliferae Y. T. Ma[J]. Zhong Cao Yao, 1984,15(3):21-23
[11] 高广猷, 李淑媛, 王勖 . 山麦冬水溶性提取物抗心肌缺血作用的实验观察[J]. 大连医学院学报, 1985,7(3):25-27
Gao GY, Li SY, Wang X . Experimental observation on the effects of anti-myocardial ischemia of Liriope spicata(Thunb.) Lour. var. proliferae Y.T. Ma water soluble extract[J]. Dalian Yi Xue Yuan Xue Bao, 1985,7(3):25-27
[12] 高广猷, 宋晓亮, 叶丽虹 . 山麦冬总氨基酸对大鼠实验性心肌缺血的保护作用[J]. 中国药理学通报, 1993,9(4):281-284
Gao GY, Song XL, Ye LH . Effect of total amino acid of Liriope spicata(Thunb.) Lour. var. proliferae Y.T. Ma on experimental myocardial ischemia[J]. Zhongguo Yao Li Xue Tong Bao, 1993,9(4):281-284
[13] 宋晓亮, 高广猷, 叶丽虹 . 山麦冬总皂苷对实验性心肌缺血的影响[J]. 中国药理学通报, 1996,12(4):329-332
Song XL, Gao GY, Ye LH . Effects of total saponin of Liriope spicata(Thunb.) Lour. var. proliferae Y. T. Ma on experimental myocardial ischemia[J]. Zhongguo Yao Li Xue Tong Bao, 1996,12(4):329-332
[14] 余伯阳, 殷霞, 徐国钧 . 短葶山麦冬的药理活性研究[J]. 中草药, 1991,14(4):37-39
Yu BY, Yin X, Xu GJ . Research on the pharmacological activities of Liriopes muscari.(Decne.) Beilg[J]. Zhong Cao Yao, 1991,14(4):37-39
[15] 余伯阳, 殷霞, 徐国钧 , 等. 湖北麦冬与浙麦冬质量的研究——免疫活性比较[J]. 中国中药杂志, 1991,16(10):584-585
Yu BY, Yin X, Xu GJ , et al. Comparison of immunological activities between the Liriope spicata(Thunb.) Lour. var. proliferae Y. T. Ma and Zhejiang Province Ophiopogon japonicus(L. f.) Ker-Gawl.(O. chekiangensis K. Kimura)[J]. Zhongguo Zhong Yao Za Zhi, 1991,16(10):584-585
[16] 余伯阳, 殷霞, 荣祖元 , 等. 短葶山麦冬皂苷C的药理活性研究[J]. 中国药科大学学报, 1994,25(5):286-288
Yu BY, Yin X, Rong ZY , et al. Pharmacological activities of ruscogenin 1-O-[β-D-glucopyranoside(1→2)] [β-D-xylopyranosyl(1→3)]-β-D-fucopyranoside from tubers roots of Liriope muscari(Decne.) Bailey[J]. Zhongguo Yao Ke Da Xue Xue Bao, 1994,25(5):286-288
[17] Wu FH, Cao JS, Jiang JJ , et al. Ruscogenin glycoside(Lm-3) isolated from Liriope muscari improves liver injury by dysfunctioning liver-infiltrating lymphocytes[J]. J Pharm Pharmacol, 2001,( 53):681-688
[18] 徐强, 王蓉, 余伯阳 . 短葶山麦冬皂苷C对迟发型变态反应及炎症反应的影响[J]. 中国药科大学学报, 1993,24(2):98-101
Xu Q, Wang R, Yu BY . Effects of ruscogenine fucopyranoside on the delayed type hypersensitivity and inflammatory reactions[J]. Zhongguo Yao Ke Da Xue Xue Bao, 1993,24(2):98-101
[19] Hur J, Lee P, Kim J , et al. Induction of nerve growth factor by butanol fraction of Liriope platyphylla in C6 and primary astrocyte cells[J]. Bio Pharm Bull, 2004,27(8):1257-1260
[1] Eric Wei Chiang Chan, Siu Kuin Wong, Hung Tuck Chan. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. Journal of Integrative Medicine, 2021, 19(4): 311-316.
[2] Pukar Khanal, Basanagouda M. Patil. Integration of network and experimental pharmacology to decipher the antidiabetic action of Duranta repens L.. Journal of Integrative Medicine, 2021, 19(1): 66-77.
[3] Zi-jia Zhang, Wen-yong Wu, Jin-jun Hou, Lin-lin Zhang, Fei-fei Li, Lei Gao, Xing-dong Wu, Jing-ying Shi, Rong Zhang, Hua-li Long, Min Lei, Wan-ying Wu, De-an Guo, Kai-xian Chen, Lewis A. Hofmann, Zhonghua Ci. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MSE analysis. Journal of Integrative Medicine, 2020, 18(3): 229-241.
[4] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[5] Deng-hai Zhang, Kun-lun Wu, Xue Zhang, Sheng-qiong Deng, Bin Peng. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 2020, 18(2): 152-158.
[6] Kayode Ezekiel Adewole. Nigerian antimalarial plants and their anticancer potential: A review. Journal of Integrative Medicine, 2020, 18(2): 92-113.
[7] Yogesh Subhash Biradar, Swathi Bodupally, Harish Padh. Evaluation of antiplasmodial properties in 15 selected traditional medicinal plants from India. Journal of Integrative Medicine, 2020, 18(1): 80-85.
[8] Dona Nirmani Ann Wijewickrama Samarakoon, Deepthi Inoka Uluwaduge, Malith Aravinda Siriwardhene. Mechanisms of action of Sri Lankan herbal medicines used in the treatment of diabetes: A review. Journal of Integrative Medicine, 2020, 18(1): 13-20.
[9] Zienab Mahmoudpour, Javad Shokri, Mohammad Kamalinejad, Neda Meftah, Soraya Khafri, Seyyed Ali Mozaffarpur, Hoda Shirafkan. The efficacy of a Persian herbal formulation on functional bloating: A double-blind randomized controlled trial. Journal of Integrative Medicine, 2019, 17(5): 344-350.
[10] Shipra Shah, Jahangeer A. Bhat. Ethnomedicinal knowledge of indigenous communities and pharmaceutical potential of rainforest ecosystems in Fiji Islands. Journal of Integrative Medicine, 2019, 17(4): 244-249.
[11] Deepak Kumar Semwal, Ashutosh Chauhan, Ankit Kumar, Sonali Aswal, Ruchi Badoni Semwal, Abhimanyu Kumar. Status of Indian medicinal plants in the International Union for Conservation of Nature and the future of Ayurvedic drugs: Shouldn’t think about Ayurvedic fundamentals?. Journal of Integrative Medicine, 2019, 17(4): 238-243.
[12] Baxter Blonk, Ian E. Cock. Interactive antimicrobial and toxicity profiles of Pittosporum angustifolium Lodd. extracts with conventional antimicrobials. Journal of Integrative Medicine, 2019, 17(4): 261-272.
[13] Hanae Naceiri Mrabti, Nidal Jaradat, Mohamed Reda Kachmar, Abdelaziz Ed-Dra, Abdelilah Ouahbi, Yahia Cherrah, Moulay El Abbes Faouzi. Integrative herbal treatments of diabetes in Beni Mellal region of Morocco. Journal of Integrative Medicine, 2019, 17(2): 93-99.
[14] Neeraj K. Sethiya, Nasir M. Ahmed, Raeesh M. Shekh, Vivek Kumar, Pawan Kumar Singh, Vipin Kumar. Ethnomedicinal, phytochemical and pharmacological updates on Hygrophila auriculata (Schum.) Hiene: An overview. Journal of Integrative Medicine, 2018, 16(5): 299-311.
[15] The Su Moe, Htet Htet Win, Thin Thin Hlaing, War War Lwin, Zaw Min Htet, Khin Mar Mya . Evaluation of in vitro antioxidant, antiglycation and antimicrobial potential of indigenous Myanmar medicinal plants. Journal of Integrative Medicine, 2018, 16(5): 358-366.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228
Journal of Integrative Medicine, ISSN: 2095-4964 CN 31-2083/R
Copyright © Journal of Integrative Medicine
Powered by Beijing Magtech Co. Ltd
沪公网安备31010602003416号      沪ICP备18017633号-3